Hikma Pharmaceutical reported 1.22B in Sales Revenues for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
AstraZeneca AZN:LN 9866M 1646M
Bayer BAYN:GR € 9781M 1073M
Fresenius FRE:GR € 9324M 78M
Fresenius Medical Care FMS:US $ 4441M 120.83M
Galapagos GLPG:NA € 76.97M 76.1M
Genmab GEN:DC DK 2310M 338M
GlaxoSmithKline GSK:LN 9077M 985M
GRIFOLS GRF:SM € 1351.9M 167.16M
H. Lundbeck A/S LUN:DC 4.01B 53M
Hikma Pharmaceutical HIK:LN 1.22B 7M
Lonza Group LONN:SW 2.54B 1.11B
Merck MRK:GR € 4973M 103M
Orion ORNBV:FH € 240.9M 14M
Recordati REC:IM € 385.35M 0.64M